Isis Pharmaceuticals Inc (NASDAQ:ISIS)

63.65
Data as of Dec 26
 +4.16 / +6.99%
Today’s Change
22.25
Today|||52-Week Range
67.12
+59.76%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$7.5B

Company Description

Isis Pharmaceuticals, Inc. engages in the development and commercialization of drugs to treat various health conditions, including inflammatory, viral, metabolic and cardiovascular and dermatological diseases and cancer. The company operates in two segments: Drug Discovery & Development and Regulus. The Drug Discovery & Development segment exploits a novel drug discovery platform created to generate a broad pipeline of first-in-class drugs for the company and for its partners. The Regulus segment focuses on developing microRNA-targeted therapeutics in cancer, fibrosis, metabolic disorders and inflammatory disorders. Isis Pharmaceuticals was founded by Stanley T. Crooke in January 1989 and is headquartered in Carlsbad, CA.

Contact Information

Isis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad California 92010
P:(760) 931-9200
Investor Relations:
(760) 603-2331

Employees

Shareholders

Mutual fund holders61.60%
Individual stakeholders6.95%
Other institutional29.48%

Top Executives

Stanley T. CrookeChairman, President & Chief Executive Officer
B. Lynne ParshallChief Operating Officer, Secretary & Director
Elizabeth L. HougenChief Financial Officer & Senior Vice President
C. Frank BennettSenior Vice President-Research
Brett P. MoniaSenior VP-Drug Discovery & Corporate Development

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.